Re(<scp>i</scp>)[2-aryl-1H-imidazo[4,5-f][1,10]phenanthroline] tricarbonyl chloride complexes for selective cancer therapy via a potential DNA damage mechanism-Reference-Cited by-同舟云学术

Re(i)[2-aryl-1H-imidazo[4,5-f][1,10]phenanthroline] tricarbonyl chloride complexes for selective cancer therapy via a potential DNA damage mechanism

Published:2024 Issue:13 Volume:53 Page:5993-6005
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Babu Lavanya Thilak¹,Das Utpal¹^ORCID,Das Rishav¹,Kar Binoy¹^ORCID,Paira Priyankar¹^ORCID

Affiliation:

1. Department of Chemistry, School of advanced sciences, Vellore Institute of Technology, Vellore-632014, Tamil Nadu, India

Abstract

Rhenium (i)-based 2-arylimidazopenantroline tricarbonyl complexes show potential for cancer treatment via G2/M phase cell-cycle arrest in association with the generation of reactive oxygen species (ROS).

Funder

Indian Council of Medical Research

VIT University

Department of Science & Technology, Ministry of Science and Technology, India

Science and Engineering Research Board

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/DT/D3DT04383E

Reference28 articles.

1. Cancer is a Preventable Disease that Requires Major Lifestyle Changes

2. Metal-based drugs that break the rules

3. The side effects of platinum-based chemotherapy drugs: a review for chemists

4. Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches

5. Organometallic and coordination rhenium compounds and their potential in cancer therapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer phototherapy by CO releasing terpyridine-based Re(i) tricarbonyl complexes via ROS generation and NADH oxidation;Dalton Transactions;2024